TrademarkOpen
Search / United States / 98157840

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

RING

Registered
Used for: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic…
Show more

Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmace…

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 2 Sep 2023
    Application filed
    New Application Entered
  2. 28 Nov 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 29 Nov 2023
    Approved for publication
    Approved For Pub - Principal Register
  4. 2 Jan 2024
    Published for opposition
    Published For Opposition
  5. 27 Feb 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 27 Aug 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 17 Oct 2024
    Statement of use filed
    Teas Statement Of Use Received
  8. 31 Jan 2025
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  9. 25 Feb 2025
    Registered on the Principal Register
    Registered-Principal Register
All 23 events
2025-02-25Registered-Principal Register
2025-02-25Notice Of Registration Confirmation Emailed
2025-01-31Allowed Principal Register - Sou Accepted
2025-01-31Notice Of Acceptance Of Statement Of Use E-Mailed
2025-01-04Case Assigned To Intent To Use Paralegal
2025-01-04Statement Of Use Processing Complete
2024-10-17Teas Statement Of Use Received
2024-10-17Use Amendment Filed
2024-08-27Sou Teas Extension Received
2024-08-27Sou Extension 1 Filed
2024-08-27Sou Extension 1 Granted
2024-08-27Notice Of Approval Of Extension Request E-Mailed
2024-02-27Noa Mailed - Sou Required From Applicant
2024-01-02Published For Opposition
2024-01-02Official Gazette Publication Confirmation E-Mailed
2023-12-26Teas Change Of Owner Address Received
2023-12-26Applicant/Correspondence Changes (Non-Responsive) Entered
2023-12-26Teas Change Of Correspondence Received
2023-12-13Notification Of Notice Of Publication E-Mailed
2023-11-29Approved For Pub - Principal Register
2023-11-28Assigned To Examiner
2023-09-27New Application Office Supplied Data Entered
2023-09-02New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmace…

First use anywhere 16 Sep 2024 · First use in commerce 16 Sep 2024

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 25 Feb 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.